西爾公司
US ˙ NasdaqGS ˙ US81578P1066

簡介

本頁面提供了有關 David Hallal 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示David Hallal已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:SRRK / Scholar Rock Holding Corporation Chief Executive Officer, Director 1,639,034
US:ITOS / iTeos Therapeutics, Inc. Director 0
US:SEER / Seer, Inc. Director 355,128
US:ALVR / AlloVir, Inc. Director, 10% Owner 2,143,662
US:US00C4W3Z001 / Alexion Pharmaceuticals, Inc. CEO, Director 189,266
如何解讀這些圖表

以下圖表顯示了在David Hallal進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

SEER / Seer, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 SEER / Seer, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SEER / Seer, Inc. Insider Trades
SEER / Seer, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 SEER / Seer, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SEER / Seer, Inc. Insider Trades
SRRK / Scholar Rock Holding Corporation內部人士買入 - 短期收益分析

在這一部分,我們分析了在 SEER / Seer, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SRRK / Scholar Rock Holding Corporation Insider Trades
SRRK / Scholar Rock Holding Corporation內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 SEER / Seer, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2026-04-16 SRRK Hallal David 30,615 49.5745 30,615 49.5745 1,517,723 48 44.6400 -151,069 -9.95
2026-01-13 SRRK Hallal David 57,450 42.7000 57,450 42.7000 2,453,115

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SRRK / Scholar Rock Holding Corporation Insider Trades
歷史內部人交易

該表格顯示了由 David Hallal 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-04-20 2026-04-16 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -30,615 1,639,034 -1.83 49.57 -1,517,723 81,254,291
2026-02-11 2026-02-09 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 128,004 1,669,649 8.30
2026-01-15 2026-01-13 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -57,450 1,541,645 -3.59 42.70 -2,453,115 65,828,242
2025-10-09 2025-10-08 4 SRRK Scholar Rock Holding Corp
Common Stock
G - Gift -205,000 1,599,095 -11.36
2025-06-06 2025-06-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -38,228 0 -100.00 10.24 -391,455
2025-06-06 2025-06-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise X 38,228 38,228 4.30 164,380 164,380
2025-06-06 2025-06-05 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -38,227 0 -100.00 10.15 -388,004
2025-06-06 2025-06-05 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise X 38,227 38,227 4.30 164,376 164,376
2025-06-06 2025-06-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -38,227 0 -100.00 10.07 -384,946
2025-06-06 2025-06-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise X 38,227 38,227 4.30 164,376 164,376
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 1,250,000 1,804,095 225.59
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 250,000 554,095 82.21
2024-07-01 2024-06-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 13,500 304,095 4.65
2024-06-14 2024-06-12 4 SEER Seer, Inc.
Class A Common Stock
A - Award 58,178 355,128 19.59
2024-06-07 2024-06-06 4 ALVR Allovir, Inc.
Common Stock
A - Award 35,000 2,143,662 1.66
2023-06-16 2023-06-14 4 SEER Seer, Inc.
Class A Common Stock
A - Award 23,443 296,950 8.57
2023-05-12 2023-05-11 4 ALVR Allovir, Inc.
Common Stock
A - Award 35,000 2,108,662 1.69
2022-10-21 2022-10-19 4 ALVR Allovir, Inc.
Common Stock
S - Sale -600,000 138,153 -81.28 8.45 -5,070,000 1,167,393
2022-09-30 2022-09-29 4 ALVR Allovir, Inc.
Common Stock
S - Sale -400,000 720,965 -35.68 7.35 -2,940,920 5,300,751
2022-08-01 2022-07-28 4 ALVR Allovir, Inc.
Common Stock
A - Award 3,253,796 16,674,766 24.24 4.61 15,000,000 76,870,671
2022-07-21 2022-07-21 4 ALVR Allovir, Inc.
Common Stock
S - Sale X -4,227 2,073,662 -0.20 5.33 -22,528 11,051,582
2022-06-17 2022-06-15 4 SEER Seer, Inc.
Class A Common Stock
A - Award 9,945 273,507 3.77
2022-06-10 2022-06-09 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -1,171 0 -100.00 19.51 -22,846
2022-06-10 2022-06-09 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 1,171 1,171 4.23 4,953 4,953
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -10,577 0 -100.00 19.86 -210,059
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 10,577 10,577 4.23 44,741 44,741
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -11,899 0 -100.00 20.39 -242,621
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 11,899 11,899 2.95 35,102 35,102
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -5,968 0 -100.00 20.39 -121,688
2022-06-10 2022-06-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 5,968 5,968 4.23 25,245 25,245
2022-06-06 2022-06-03 4 ALVR Allovir, Inc.
Common Stock
S - Sale X -65,725 2,077,889 -3.07 3.67 -241,106 7,622,528
2022-05-27 2022-05-26 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 28,000 28,000
2022-05-19 2022-05-17 4 ALVR Allovir, Inc.
Stock Option (Right to Buy)
A - Award 27,500 27,500
2022-04-22 2022-04-21 4 ALVR Allovir, Inc.
Common Stock
S - Sale X -4,227 2,143,614 -0.20 5.87 -24,812 12,583,014
2022-03-11 2022-03-11 4 ALVR Allovir, Inc.
Common Stock
S - Sale X -25,244 2,147,841 -1.16 7.37 -186,068 15,831,306
2022-03-11 2022-03-10 4 ALVR Allovir, Inc.
Common Stock
S - Sale X -40,481 2,173,085 -1.83 7.55 -305,781 16,414,832
2022-01-25 2022-01-24 4 ALVR Allovir, Inc.
Common Stock
S - Sale -17,100 2,213,566 -0.77 8.01 -136,889 17,720,039
2021-12-22 2021-12-20 4 ITOS iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -30,000 37,039 -44.75
2021-12-22 2021-12-20 4 ITOS iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -20,000 114,682 -14.85
2021-12-22 2021-12-20 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -50,000 0 -100.00 43.57 -2,178,500
2021-12-22 2021-12-20 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 30,000 50,000 150.00 2.95 88,500 147,500
2021-12-22 2021-12-20 4 ITOS iTeos Therapeutics, Inc.
Common Stock
M - Exercise 20,000 20,000 4.30 86,000 86,000
2021-06-22 2021-06-17 4 SEER Seer, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2021-06-21 2021-06-17 4 ITOS iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16,608 16,608
2021-06-01 2021-05-27 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 7,800 7,800
2021-05-27 2021-05-25 4 ALVR Allovir, Inc.
Stock Option (Right to Buy)
A - Award 22,500 22,500
2021-01-25 2021-01-21 4 ALVR Allovir, Inc.
Stock Option (Right to Buy)
A - Award 273,000 273,000
2021-01-25 2021-01-21 4 ALVR Allovir, Inc.
Common Stock
A - Award 147,000 2,230,666 7.05
2020-12-11 2020-12-03 4 SEER Seer, Inc.
Stock Option (right to buy)
A - Award 18,691 18,691
2020-12-03 3 SEER Seer, Inc.
Class A Common Stock
263,562
2020-10-21 2020-07-23 4/A ITOS iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16,608 0 -100.00
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Series A-4 Convertible Preferred Stock
C - Conversion -1,100,000 0 -100.00
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Series A-4 Convertible Preferred Stock
C - Conversion -233,333 0 -100.00
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -20,000,000 0 -100.00
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Common Stock
C - Conversion 738,153 738,153
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Common Stock
C - Conversion 156,577 1,120,965 16.24
2020-08-05 2020-08-03 4 ALVR Allovir, Inc.
Common Stock
C - Conversion 13,420,970 13,420,970
2020-07-31 2020-07-29 4 ALVR Allovir, Inc.
Stock Option (Right to Buy)
A - Award 1,101,000 1,101,000
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
5,131,720
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
4,012,442
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
5,131,720
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
4,012,442
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
5,131,720
2020-07-30 3 ALVR Allovir, Inc.
Common Stock
4,012,442
2020-07-24 2020-07-23 4 ITOS iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16,608 0 -100.00
2020-06-18 2020-06-16 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 7,000 7,000
2020-06-18 2020-06-16 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 13,000 13,000
2019-09-20 2019-09-18 4 SRRK Scholar Rock Holding Corp
Common Stock
G - Gift -2,000 290,595 -0.68
2019-05-23 2019-05-21 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 10,158 10,158
2018-06-26 2018-06-22 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 20,316 20,316
2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock
585,190
2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock
585,190
2016-08-10 2016-08-08 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -332 189,266 -0.18 137.14 -45,530 25,955,939
2016-04-05 2016-04-01 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -34 189,598 -0.02 136.21 -4,631 25,825,144
2016-04-05 2016-04-01 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,380 189,632 -0.72 135.87 -187,501 25,765,300
2016-03-01 2016-02-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -14 191,012 -0.01 141.45 -1,980 27,018,647
2016-03-01 2016-02-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -2,000 191,026 -1.04 138.91 -277,820 26,535,422
2016-03-01 2016-02-26 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 131,000 131,000 140.16 18,360,960 18,360,960
2016-03-01 2016-02-26 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 20,000 193,026 11.56
2016-02-08 2016-02-08 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -3,492 173,026 -1.98 138.02 -481,966 23,881,049
2016-02-08 2016-02-08 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -117 176,518 -0.07 139.18 -16,284 24,567,775
2016-02-08 2016-02-08 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -337 176,635 -0.19 138.02 -46,513 24,379,163
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,490 176,972 -0.83 140.49 -209,330 24,862,796
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -3,710 178,462 -2.04 141.40 -524,594 25,234,527
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -712 182,172 -0.39 142.35 -101,353 25,932,184
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -300 182,884 -0.16 143.45 -43,035 26,234,710
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -400 183,184 -0.22 144.45 -57,780 26,460,929
2016-02-08 2016-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -110 183,584 -0.06 145.01 -15,951 26,621,516
2016-02-08 2016-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 41,136 183,694 28.86
2016-02-08 2016-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -10 142,558 -0.01 145.05 -1,450 20,678,038
2016-02-08 2016-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -619 142,568 -0.43 143.81 -89,018 20,502,704
2015-08-11 2015-08-07 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -329 143,187 -0.23 190.01 -62,513 27,206,962
2015-08-05 2015-08-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -612 143,516 -0.42 196.52 -120,270 28,203,764
2015-04-02 2015-03-31 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 49,275 49,275 173.30 8,539,358 8,539,358
2015-04-02 2015-03-31 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 11,270 144,128 8.48
2015-03-03 2015-03-02 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -730 132,858 -0.55 180.34 -131,648 23,959,612
2015-03-03 2015-02-27 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 7,626 7,626
2015-03-03 2015-02-27 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 32,200 32,200
2015-03-03 2015-02-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2,265 133,588 1.72
2015-03-03 2015-02-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 7,290 131,323 5.88
2015-02-12 2015-02-10 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,980 124,033 -1.57 171.15 -338,877 21,228,248
2015-02-09 2015-02-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -2,920 126,013 -2.26 173.93 -507,876 21,917,441
2015-02-09 2015-02-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 11,690 128,933 9.97
2015-02-05 2015-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -608 117,243 -0.52 174.38 -106,023 20,444,834
2015-02-05 2015-02-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -765 117,851 -0.64 174.02 -133,125 20,508,431
2014-12-19 2014-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -5,494 113,122 -4.63 182.03 -1,000,073 20,591,598
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -14,336 0 -100.00 17.65 -253,030
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -15,664 84,336 -15.66 22.90 -358,706 1,931,294
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -14,336 118,616 -10.78 190.02 -2,724,127 22,539,412
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -15,664 132,952 -10.54 190.00 -2,976,160 25,260,880
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 14,336 148,616 10.68 17.65 253,030 2,623,072
2014-11-04 2014-11-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 15,664 134,280 13.21 22.90 358,706 3,075,012
2014-08-05 2014-08-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,349 118,616 -1.12 158.00 -213,142 18,741,328
2014-03-04 2014-02-28 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 49,200 49,200
2014-03-04 2014-02-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 6,000 119,965 5.26
2014-02-10 2014-02-07 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -10 113,965 -0.01 158.05 -1,580 18,012,168
2014-02-10 2014-02-07 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,600 113,975 -1.38 155.55 -248,880 17,728,811
2014-02-10 2014-02-06 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -10 113,965 -0.01 156.95 -1,570 17,886,807
2014-02-10 2014-02-06 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 9,745 115,575 9.21
2014-02-05 2014-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -2,390 105,830 -2.21 153.63 -367,176 16,258,663
2014-02-05 2014-02-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -729 108,220 -0.67 157.14 -114,555 17,005,691
2014-01-31 2014-01-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -29 108,949 -0.03 133.37 -3,868 14,530,528
2014-01-31 2014-01-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -700 108,978 -0.64 133.45 -93,415 14,543,114
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise X -15,363 0 -100.00 17.98 -276,227
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise X -7,295 0 -100.00 17.98 -131,164
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -15,363 109,678 -12.29 127.61 -1,960,472 13,996,010
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award X 15,363 125,041 14.01 17.98 276,227 2,248,237
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -7,295 109,678 -6.24 127.53 -930,331 13,987,235
2013-12-20 2013-12-18 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 7,295 116,973 6.65 17.98 131,164 2,103,175
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise X -14,637 15,363 -48.79 17.98 -263,173 276,227
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise X -10,705 7,295 -59.47 17.98 -192,476 131,164
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -14,637 109,678 -11.77 127.63 -1,868,120 13,998,203
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 14,637 124,315 13.35 17.98 263,173 2,235,184
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -10,705 109,678 -8.89 127.63 -1,366,279 13,998,203
2013-12-11 2013-12-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 10,705 120,383 9.76 17.98 192,476 2,164,486
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -18,000 18,000 -50.00 17.98 -323,640 323,640
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -7,963 88,178 -8.28 123.77 -985,581 10,913,791
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -22,037 96,141 -18.65 122.79 -2,705,923 11,805,153
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 30,000 118,178 34.02 17.98 539,400 2,124,840
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -4,777 88,178 -5.14 123.77 -591,249 10,913,791
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -13,223 92,955 -12.45 122.79 -1,623,652 11,413,944
2013-10-30 2013-10-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 18,000 106,178 20.41 17.98 323,640 1,909,080
2013-08-07 2013-08-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -730 88,178 -0.82 116.87 -85,315 10,305,363
2013-08-01 2013-07-30 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -746 88,908 -0.83 110.86 -82,702 9,856,341
2013-07-16 2013-07-12 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -50,000 14,336 -77.72 17.65 -882,500 253,030
2013-07-16 2013-07-12 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale X -50,000 89,654 -35.80 120.00 -6,000,000 10,758,480
2013-07-16 2013-07-12 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise X 50,000 139,654 55.77 17.65 882,500 2,464,893
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -5,664 0 -100.00 17.65 -99,970
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -5,692 0 -100.00 11.92 -67,849
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -3,128 0 -100.00 10.29 -32,187
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -524 0 -100.00 8.16 -4,276
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 5,664 89,654 6.74 17.65 99,970 1,582,393
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 5,692 83,990 7.27 11.92 67,849 1,001,161
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 3,128 78,298 4.16 10.29 32,187 805,686
2013-06-07 2013-06-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 524 75,170 0.70 8.16 4,276 613,387
2013-02-08 2013-02-06 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 73,000 73,000
2013-02-08 2013-02-06 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 5,400 74,646 7.80
2013-02-06 2013-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -985 69,246 -1.40 96.74 -95,289 6,698,858
2013-02-06 2013-02-04 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,100 70,231 -1.54 95.68 -105,248 6,719,702
2013-01-30 2013-01-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -512 71,331 -0.71 94.32 -48,292 6,727,940
2013-01-30 2013-01-28 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -632 71,843 -0.87 94.50 -59,724 6,789,164
2012-10-26 2012-10-24 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -10,500 524 -95.25
2012-10-26 2012-10-24 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 10,500 72,475 16.94 8.16 85,680 591,396
2012-07-31 2012-07-31 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -680 61,975 -1.09 104.99 -71,393 6,506,755
2012-07-31 2012-07-27 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -50,000 64,336 -43.73
2012-07-31 2012-07-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -555 62,655 -0.88 106.14 -58,908 6,650,202
2012-07-31 2012-07-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -50,000 63,210 -44.17 107.74 -5,387,000 6,810,245
2012-07-31 2012-07-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 50,000 113,210 79.10 17.65 882,500 1,998,156
2012-06-19 2012-06-15 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -14,308 0 -100.00
2012-06-19 2012-06-15 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -14,308 63,210 -18.46 93.67 -1,340,230 5,920,881
2012-06-19 2012-06-15 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 14,308 77,518 22.64 11.92 170,551 924,015
2012-05-11 2012-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -10,000 84,710 -10.56
2012-05-11 2012-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 10,000 63,210 18.79 8.16 81,600 515,794
2012-02-24 2012-02-23 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -40,000 14,308 -73.65
2012-02-24 2012-02-23 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -40,000 53,210 -42.91 85.50 -3,420,000 4,549,455
2012-02-24 2012-02-23 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 40,000 93,210 75.17 11.92 476,800 1,111,063
2012-02-06 2012-02-03 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise 77,000 77,000
2012-02-06 2012-02-03 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 10,000 53,210 23.14
2012-01-30 2012-01-30 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -1,896 39,749 -4.55 74.51 -141,271 2,961,698
2012-01-30 2012-01-27 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
S - Sale -554 41,645 -1.31 74.41 -41,223 3,098,804
2012-01-04 2011-12-30 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
M - Exercise -3,000 21,024 -12.49
2012-01-04 2011-12-30 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
M - Exercise 3,000 42,735 7.55 8.16 24,480 348,718
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)